Innovent Biologics Technology Limited (shanghai R&d Center)

This early-stage study is testing the safety and side effects of a new weight management drug called IBI3032 in people who are overweight or have obesity. The trial involves 79 participants who will receive either the drug or a placebo over 4 weeks. Researchers are primarily chec…